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Hepatitis B virus (HBV) is the prototype of the family Hepadnaviridae, which 
causes liver disease in humans, mammals and birds. The envelope of HBV contains 
three related surface antigens (termed L-, M- and S-HBsAg) produced by 
alternative initiation of translation in a single coding region. These polypeptides 
harbour a common 226 amino acids at their C-terminus, which is also the entire 
length of the S-HBsAg. The M-HBsAg contains an N-terminal extension of 55 
amino acids known as the PreS2 region. The longest of the three, L-HBsAg, has the 
PreS 1 region of 108 or 119 amino acids (depending on serotype) followed by the 
PreS2 and the S regions. The PreS domain is believed to be involved in virion 
assembly and attachment to a hepatocyte receptor during infection. In order to 
study the functions of this region, the PreS and PreS 1 domains were fused to the 
g3p protein of bacteriophage Ml3 and lOB protein of bacteriophage T7, 
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respectively, that allow the fusion proteins to be displayed. The PreS-g3p fusion 
protein produced in a suppressor strain of Escherichia coli was detected by the anti­
E tag antibody with a size of approximately 66 kDa on a Western blot. In a non­
suppressor strain of E. coli, the soluble PreS protein was detected in the medium, 
periplasm and cytoplasm with a molecular mass of approximately 22 kDa. 
Meanwhile in the T7 system, the first and second halves of PreS 1 were detected by 
the T7 Tag antibody on a Western blot with a size of around 50 kDa. The 
functional display of the PreS region would provide an alternative means to study 
its interactions with the nucleocapsid and hepatocytes. Precise definition of the 
regions and specific amino acids in L-HBsAg that are required for efficient 
interaction with the nucleocapsid and hepatocytes, may help to identify lead 
compounds for therapeutic agents based upon inhibition of viral morphogenesis. 
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Virus Hepatitis B (HBV) adalah prototaip famili Hepadnaviridae yang 
menyebabkan penyakit hati pada manusia, mamalia dan burung. Penyalut HBV 
terdiri daripada tiga jenis antigen permukaan yang saling berkaitan (dikenali 
sebagai L-, M- dan S-HBsAg) hasil daripada tanslasi pemulaan yang berlainan 
dalam satu kawasan pengkodan. Kesemua polipeptida ini mengandungi 226 asid 
amino pada terminal-C yang juga merupakan keseluruhan polipeptida S-HBsAg. 
M-HBsAg mengandungi 55 asid amino terlunjur dari terminal-N yang dikenali 
sebagai kawasan PreS2. L-HBsAg yang merupakan polipeptida terpanjang antara 
ketiga-tiga polipeptida tersebut, mengandungi kawasan PreS 1 yang terdiri daripada 
108 atau 119 asid amino (bergantung pada serotaip), diikuti oleh kawasan PreS2 
dan kawasan S. Kawasan PreS adalah dipercayai terlibat dalam pembentukan virus 
dan pelekatan pada reseptor hepatosit semasa jangkitan. Demi mengkaji fungsi 
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kawasan ini, kawasan PreS dan PreS I , masing-masing, digabungkan dengan 
protein g3p pada M13 dan protein lOB pada T7 yang membenarkan gabungan 
protein tersebut dipersembahkan. Gabungan protein PreS-g3p yang dihasilkan oleh 
strain tertindas Escherichia coli dapat dikesan dengan antibodi anti-E tag dengan 
saiz lebih kurang 66 kDa pada pemblotan Western. Pada strain tak-tertindas E. coli, 
protein PreS terlarut dikesan di dalam medium, periplasma dan sitoplasma dengan 
jisim molekul lebih kurang 22 kDa. Sementara itu, dalam sistem T7, separuh 
pertama dan kedua PreS 1 dapat dikes an dengan antibodi T7 Tag pada pemblotan 
Western dengan saiz berukuran sekitar 50 kDa. Persembahan berfungsi kawasan 
PreS akan membekalkan satu cara alternatif untuk mengkaji interaksinya dengan 
nukleokapsid dan hepatosit. Definisi yang tepat terhadap kawasan terlibat serta asid 
amino spesifik pada L-HBsAg yang berkesan dalam interaksi nukleokapsid dan 
hepatosit mungkin dapat membantu dalam penentuan sebatian untuk dijadikan 
sebagai agen terapeutik berdasarkan kepada perencatan morfogenesis virus. 
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CHAPTER! 
INTRODUCTION 
Hepatitis B viruses are a group of small enveloped hepatotropic partially double­
stranded DNA viruses that cause acute and chronic infections in humans, mammals 
and birds (Mason and Seeger, 1 991) .  Chronic infection of HBV is estimated to 
occur in -300 million people world-wide, these people have an increase risk of 
developing cirrhosis and hepatocellular carcinoma. Thus, hepatitis B is a major 
world-wide health problem today (Hildt et ai. ,  1 996). 
Despite the widespread use of effective vaccmes based on surface antigens 
(HBsAg) derived from human plasma (Szmuness et ai. ,  1 980) or produced in yeast 
resulting from recombinant DNA approaches (Valenzuela et ai., 1 982; Murray et 
ai. ,  1 984), HBV infections are responsible for 1 -2 million deaths annually 
(Mahoney, 1999). To date, only interferon alfa and lamivudine monotherapy have 
been approved in many countries for the treatment of chronic HB V infection (Lok 
et ai. ,  1 993). Moreover, the success rate for these treatments is less than 50%, 
therefore, development of an improved vaccine, a rapid and sensitive diagnostic 
test and antiviral compounds are greatly in need to control the disease. 
The causative agent of hepatitis B, the Dane particle, consists of an inner 
nucleocapsid, comprising the core protein (HBcAg), viral polymerase and viral 
1 
DNA, surrounded by a membranous envelope containing viral surface antigens 
(HBsAg). There are three surface antigens: large (L), medium (M) and short (S), 
which share a common C-terminal region but have different N-termini, arising 
from variable use of different initiation triplets within a continuous open reading 
frame (Ganem and Varmus, 1987). The L-polypeptide consists of PreS 1 ,  PreS2 and 
S regions, whereas the M-polypeptide consists of PreS2 and S regions (Heermann 
et ai. , 1984). 
All these surface antigens were shown to elicit virus-neutralizing and protective 
antibodies (Itoh et ai., 1 986). Antibodies directed against PreS region correlate with 
viral clearance and recovery from acute HBV infection and the antibodies response 
to PreS can overcome nonresponsiveness to S region in the currently available 
vaccine (Milich et ai., 1 985). It has been reported that inclusion of the PreS region 
into the commercially available vaccines could result in enhanced antibody 
response to S region and thus provide a more effective vaccine for HBV (Neurath 
et ai., 1989). In addition, the PreS 1 and PreS2 regions have been shown to play an 
important role in the attachment to HBV hepatocyte receptor (Neurath et ai., 1986; 
Pontisso et ai. , 1 989). 
Earlier work has shown that L-HBsAg binds to the core protein in vitro (Dyson and 
Murray, 1995). Furthermore, using phage display libraries, peptides were selected, 
in which they bound to the core protein and blocked the binding of L-HBsAg to the 
core protein (Dyson and Murray, 1995). Different mutagenesis experiments 
2 
demonstrated that virion morphogenesis required the 17 C-terminal amino acids of 
the PreS 1 region and the 5 N-terminal amino acids of the PreS2 domain of the L­
HBsAg, exposed at the cytosolic face of the ER membrane (Le Seyec et aI., 1998� 
1999). Recently, mutagenesis studies have confirmed that the interaction between 
L-HBsAg with HBcAg is mediated through two distinct sites, one element contains 
the PreS domain and the other is composed of about the first two third of the S­
HBsAg (Tan et al., 1999). Besides, point mutation studies showed that Arg 92 in 
the PreS domain plays a pivotal role in the interaction (Tan et al., 1999). 
The broad diversity of peptides displayed on the surface of bacteriophage has made 
phage display a powerful tool in drug discoveries by affinity selection of specific 
ligands that interact with a particular target (Wilson and Finlay, 1998). Phage 
display differs from conventional expression systems, in that the foreign gene 
sequence is inserted into the gene encoding one of the phage coat proteins, so that 
the foreign amino acid sequence is genetically fused to the endogenous amino acids 
of the coat protein to make a hybrid "fusion protein" (Smith and Petrenko, 1997). 
The hybrid coat protein is incorporated into phage particles as they are released 
from the cell, so that the foreign peptide or protein domain is displayed on the outer 
surface. 
The most commonly utilized vectors for phage display are based on filamentous 
bacteriophage (M13, fd, fl), where the foreign peptide can be fused to the amino 
terminus of the coat proteins 3 or 8 (Scott and Smith, 1990). Molecules that have 
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been displayed either fused to the g3p or g8p of the filamentous phage include 
peptides (Smith and Scott, 1993), constrained peptides (McLafferty et aI., 1993), 
antibody-like molecules (Fab and single-chain; Winter et aI., 1994), enzymes 
(Corey et aI., 1993), enzyme inhibitors (Roberts et aI., 1992) and products of 
eDNA libraries (Hottiger et aI., 1995). 
Recently, a number of other display systems have been developed using non­
filamentous phage. These include the display of fusions to the bacteriophages 
lambda (Mikawa et ai., 1996; Santi et ai., 2000), T4 (Efimov et ai., 1995) and T7 
(Houshmand et aI., 1999). 
In order to study the development of a more effective vaccine and the receptor­
ligand interaction, it would of useful to obtain high-level expression of the PreS 
region in bacteria but has not yet been reported. Therefore, the objective of this 
study was to clone the coding fragments of PreS and PreS 1 regions and 
subsequently express them in a phagemid and T7 vector, respectively. The 
functional display of the PreS or PreS 1 regions could serve as a useful tool to 
investigate further their interactions with the viral nucleocapsid or hepatocyte 
receptor. Identification of the lead compounds for therapeutic agents based upon 
inhibition of viral morphogenesis is a quantum leap towards the control of hepatitis 
B. 
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2.1 Hepatitis B Virus 
CHAPTER 2 
LITERATURE REVIEW 
Hepatitis B virus (HBV) is a major cause of chronic inflammatory liver disease and 
liver cirrhosis associated with the development of hepatocellular carcinoma. HBV 
is an enveloped DNA virus of the hepadnavirus family (Ganem and Varmus, 1987). 
The other identified members of this family are the woodchuck hepatitis virus 
(WHV), ground squirrel hepatitis virus (GSHV), duck hepatitis virus (DHBV) and 
heron hepatitis virus (HHBV) (Seeger et aI., 1991). 
The host range of HBV is very restricted and it only infects human and 
chimpanzees (Gust et aI., 1986). The routes of infection occur by both vertical and 
horizontal transmission of the virus (Gust et aI., 1986). Vertical transmission 
occurs by the passage of HBV from an infected mother to her offspring while 
horizontal transmission happens during sexual contact and percutaneous contact or 
other close contact between the virus and man. 
HBV infection is highly polymorphic, rangmg from inapparent forms to acute 
hepatitis and severe chronic liver disease. The pathological consequences of the 
viral infection are unpredictable and the mechanism through which HBV enters 
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hepatocytes has not been resolved despite considerable understanding of the details 
of hepadnaviral genome replication (Ganem and Varmus, 1987; Nassal and 
Schaller, 1993; 1996). 
2.1.1 Morphology and Genome Structure 
Serum from individuals infected by HBV contains distinct forms of viral particles. 
Most of them are spherical or filamentous particles of about 22 nm in diameter 
(Bayer et aI., 1968; Gerin et a/., 1969). These subviral particles consist of a single 
viral envelope and are therefore not infectious. The infectious agents also known as 
Dane particles (Dane et aI., 1970), are spherical 42 nm double-shelled particles. 
The Dane particle (Figure 2.1) consists of a nucleocapsid, comprising the core 
protein (HBcAg), viral polymerase and viral DNA, surrounded by a membranous 
envelope containing viral surface antigens (HBsAg). 
S-HBsAg 
(S region) 
L-HBsAg 
PreS 1 +PreS2+S regions 
HBcAg 
DNA 
DNA polymerase 
DNA terminal protein 
Figure 2.1: A schematic representation of the structure of HBV (modified from 
Nassal and Schaller, 1993). 
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The viral envelope contains three different, but related, HBsAg polypeptides, 
known as short (S), medium (M) and long (L) polypeptides, which are encoded in a 
single open reading frame of the viral genome by using three different in-frame 
start codons and a common stop codon (Heermann et aI., 1984). The genome is a 
partially double-stranded circular DNA of only 3.2 kilobases (kb) in length, the 
smallest of any animal DNA virus yet encountered (Figure 2.2). The negative 
strand is linear and of fixed length of about 3.2 kb while the positive strand is of 
variable length. The maintenance of the circular structure of the genome is assured 
by base-pairing of the 5 '  ends of the two strands containing the viral direct repeat 
(DR) sequences. At both sides of the cohesive ends, there are II-base pair direct 
repeats (DRl and DR2), which are critically involved in the initiation of viral DNA 
synthesis (Ganem and Varmus, 1987). 
2.1.2 Genomic Organisation and Viral Transcripts 
The negative strand transcript of HBV contains four major open reading frames 
(ORFs): S, C, P and X (Figure 2.2). The coding region for HBsAg (ORF S) proved 
to be the 3' portion of a larger coding region: upstream of ORF S is an in-phase 
reading frame (ORF PreS) with two conserved in-phase ATG codons that can 
direct the synthesis of additional HBsAg related proteins which subdivide the PreS 
region into two functional subregions, termed PreS 1 and PreS2. The coding region 
for HBcAg (ORF C) is also preceded by a short upstream in-phase ORF (termed 
ORF PreC), which produces a hydrophobic polypeptide bearing hepatitis B e 
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antigen (HBeAg) and could have a role in the attachment of core to the viral 
envelope. ORF X encodes a pleiotropic transcriptional activator of yet undefined 
function for the viral life cycle. Overlapping these coding regions, ORF P, is 
believed to encode the viral polymerase (Ganem and Varmus, 1987; Nassal and 
Schaller, 1993). 
Four species of mRNA transcripts (Figure 2.2) are produced from a corresponding 
set of promoters on a covalently closed circular DNA utilizing the transcription 
machinery of the host cell. There are two classes of viral RNAs, genomic and 
subgenomic. The genomic RNAs are approximately 3.5 kb in length and their 
synthesis is controlled by the core (C) promoter (Yaginuma and Koike, 1989). 
These RNAs are bifunctional, serving not only as the mRNA for the precore, core 
and P proteins, but also as the template for reverse transcription in the DNA 
genome. The subgenomic RNAs include 2.4, 2.1 and 0.9 kb in length. The PreSI 
promoter regulates the transcription of the 2.4 kb mRNAs which serve as a 
template for the L-HBsAg (Will et aI., 1987). The 2.1 kb mRNAs encoded the M­
and S-HBsAg which are the most abundant in acutely infected livers. Synthesis of 
the 2.1 kb mRNAs is controlled by the PreS2 /S promoter (Raney et at., 1989). The 
smallest transcript, 0.9 kb, g ives rise to the X protein, HBxAg. All these transcripts 
terminate at a common position, some 20 nucleotides downstream of the conserved 
hexanucleotide TATAAA (Ganem and Varmus, 1987). 
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